Synthetic biology and precision medicine in blood and gynaecological cancers
Dr Ciprian Tomuleasa speaks to ecancer at the ASH 2019 meeting in Orlando.
He speaks about the current landscape of haematology oncology in Romania and the challenges associated with access to novel drugs in this disease.
Dr Tomuleasa concludes by addressing what needs to be done to improve cancer care in Romania.
Synthetic biology and precision medicine in blood and gynaecological cancers
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
Latest in immunological technologies that can treat, control, and prevent cancer
OncoAlert Round Up for August 4th - 10th, 2023
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC